AMENDMENT TO SEVERANCE AND CHANGE OF CONTROL AGREEMENTSeverance and Change of Control Agreement • January 27th, 2020 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledJanuary 27th, 2020 Company Industry JurisdictionTHIS AMENDMENT TO CHANGE OF CONTROL AGREEMENT between Jonathan Yingling (the "Executive") and Idera Pharmaceuticals, Inc. (''the Company'') shall be effective January 27, 2020.